| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature
|
Bentea, Georgiana
|
|
2017
|
106 |
C |
p. 83-92
10 p.
|
artikel
|
| 2 |
Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature
|
Durieux, Valérie
|
|
2017
|
106 |
C |
p. 102-109
8 p.
|
artikel
|
| 3 |
Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature
|
Holbrechts, Stéphane
|
|
2017
|
106 |
C |
p. 93-101
9 p.
|
artikel
|
| 4 |
Chest wall resection for non-small cell lung cancer: A case-matched study of postoperative pulmonary function and quality of life
|
Liu, Ming
|
|
2017
|
106 |
C |
p. 37-41
5 p.
|
artikel
|
| 5 |
Combination treatment with erlotinib and ampelopsin overcomes erlotinib resistance in NSCLC cells via the Nox2-ROS-Bim pathway
|
Hong, Seung-Woo
|
|
2017
|
106 |
C |
p. 115-124
10 p.
|
artikel
|
| 6 |
Contents
|
|
|
2017
|
106 |
C |
p. v-vi
nvt p.
|
artikel
|
| 7 |
Dual occurrence of ALK G1202R solvent front mutation and small cell lung cancer transformation as resistance mechanisms to second generation ALK inhibitors without prior exposure to crizotinib. Pitfall of solely relying on liquid re-biopsy?
|
Ou, Sai-Hong Ignatius
|
|
2017
|
106 |
C |
p. 110-114
5 p.
|
artikel
|
| 8 |
Editorial Board
|
|
|
2017
|
106 |
C |
p. iii-
1 p.
|
artikel
|
| 9 |
Effects of aspirin on small-cell lung cancer mortality and metastatic presentation
|
Maddison, Paul
|
|
2017
|
106 |
C |
p. 67-69
3 p.
|
artikel
|
| 10 |
High-risk community and primary care providers knowledge about and barriers to low-dose computed topography lung cancer screening
|
Simmons, Vani N.
|
|
2017
|
106 |
C |
p. 42-49
8 p.
|
artikel
|
| 11 |
Immune-checkpoint inhibition in first-line treatment of advanced non-small cell lung cancer patients: Current status and future approaches
|
Remon, J.
|
|
2017
|
106 |
C |
p. 70-75
6 p.
|
artikel
|
| 12 |
Impact of a planned dose interruption of dacomitinib in the treatment of advanced non-small-cell lung cancer (ARCHER 1042)
|
Kim, Dong-Wan
|
|
2017
|
106 |
C |
p. 76-82
7 p.
|
artikel
|
| 13 |
MET exon 14 skipping mutation in triple-negative pulmonary adenocarcinomas and pleomorphic carcinomas: An analysis of intratumoral MET status heterogeneity and clinicopathological characteristics
|
Kwon, Dohee
|
|
2017
|
106 |
C |
p. 131-137
7 p.
|
artikel
|
| 14 |
Mutations in TP53, PIK3CA, PTEN and other genes in EGFR mutated lung cancers: Correlation with clinical outcomes
|
VanderLaan, Paul A.
|
|
2017
|
106 |
C |
p. 17-21
5 p.
|
artikel
|
| 15 |
Oligometastatic non-small cell lung cancer: Where do we go next?
|
Malik, Nauman
|
|
2017
|
106 |
C |
p. 145-147
3 p.
|
artikel
|
| 16 |
Optimal management of ALK-positive NSCLC progressing on crizotinib
|
Metro, Giulio
|
|
2017
|
106 |
C |
p. 58-66
9 p.
|
artikel
|
| 17 |
Pilot phase II study of metronomic chemotherapy in combination with bevacizumab in patients with advanced non-squamous non-small cell lung cancer
|
Jones, Benjamin S.
|
|
2017
|
106 |
C |
p. 125-130
6 p.
|
artikel
|
| 18 |
Pirfenidone plays a biphasic role in inhibition of epithelial-mesenchymal transition in non-small cell lung cancer
|
Fujiwara, Ayako
|
|
2017
|
106 |
C |
p. 8-16
9 p.
|
artikel
|
| 19 |
Plasma epidermal growth factor receptor mutation testing with a chip-based digital PCR system in patients with advanced non-small cell lung cancer
|
Kasahara, Norimitsu
|
|
2017
|
106 |
C |
p. 138-144
7 p.
|
artikel
|
| 20 |
Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer
|
Bagley, Stephen J.
|
|
2017
|
106 |
C |
p. 1-7
7 p.
|
artikel
|
| 21 |
Renal cyst formation in patients treated with crizotinib for non-small cell lung cancer—Incidence, radiological features and clinical characteristics
|
Halpenny, Darragh F.
|
|
2017
|
106 |
C |
p. 33-36
4 p.
|
artikel
|
| 22 |
SBRT for oligoprogressive oncogene addicted NSCLC
|
Basler, L.
|
|
2017
|
106 |
C |
p. 50-57
8 p.
|
artikel
|
| 23 |
The cell-cell interaction between tumor-associated macrophages and small cell lung cancer cells is involved in tumor progression via STAT3 activation
|
Iriki, Toyohisa
|
|
2017
|
106 |
C |
p. 22-32
11 p.
|
artikel
|
Tijdschrift beschrijving